Skip to content
Subscriber Only

Drug Supply Players Point a Finger Everywhere But Themselves

  • Lobby groups to go before Senate committee on drug prices
  • Trump renewed attack on high drug prices day before hearing
Bloomberg business news

Trump vs. Big Pharma: Can He Bring Drug Prices Down?

A day after President Donald Trump renewed his attack on high drug prices, officials from the drug industry’s top lobbying groups sat down at a black cloth-draped table in a Senate hearing room and told lawmakers who’s to blame: the person a few seats over.

Drugmakers said in prepared remarks that insurers, pharmacy-benefit managers and hospitals, among others, keep a large chunk of the money Americans spend on medicine and don’t pass on savings to patients.